CCR5 status and metastatic progression in colorectal cancer.
CCL5
CCR5
T cells
colorectal cancer
disease free survival
immune checkpoint
immunotherapy
macrophages
microenvironment
Journal
Oncoimmunology
ISSN: 2162-4011
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
Historique:
received:
04
04
2019
revised:
27
05
2019
accepted:
29
05
2019
entrez:
21
8
2019
pubmed:
21
8
2019
medline:
21
8
2019
Statut:
epublish
Résumé
Multiple reports have highlighted the importance of the local immunological cellular composition (
Identifiants
pubmed: 31428524
doi: 10.1080/2162402X.2019.1626193
pii: 1626193
pmc: PMC6685512
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e1626193Références
Immunol Rev. 2000 Oct;177:99-111
pubmed: 11138790
J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):472-81
pubmed: 11511825
J Am Soc Nephrol. 2002 Mar;13(3):754-8
pubmed: 11856781
Cell Signal. 2004 Nov;16(11):1201-10
pubmed: 15337520
Int J Cancer. 2005 Oct 10;116(6):949-56
pubmed: 15856455
Cancer Res. 2005 Sep 15;65(18):8072-8
pubmed: 16166278
J Exp Med. 2005 Oct 17;202(8):1075-85
pubmed: 16230475
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
J Clin Invest. 2006 Oct;116(10):2777-90
pubmed: 17016559
Nature. 2007 Oct 4;449(7162):557-63
pubmed: 17914389
J Clin Invest. 2008 Jun;118(6):1991-2001
pubmed: 18523649
Curr Opin HIV AIDS. 2009 Mar;4(2):96-103
pubmed: 19339947
AIDS Read. 2009 Jun-Jul;19(6):218-22, 224
pubmed: 19642239
Eur J Immunol. 2010 Jan;40(1):22-35
pubmed: 19941314
Cytokine Growth Factor Rev. 2010 Feb;21(1):27-39
pubmed: 20004131
Int J Colorectal Dis. 2010 Apr;25(4):417-24
pubmed: 20054600
Curr Top Microbiol Immunol. 2011;344:1-24
pubmed: 20512556
Semin Immunopathol. 2011 Jul;33(4):335-40
pubmed: 21461991
Cancer Res. 2011 Sep 1;71(17):5670-7
pubmed: 21846824
PLoS One. 2011;6(12):e28842
pubmed: 22205974
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Cancer Res. 2012 Aug 1;72(15):3839-50
pubmed: 22637726
N Engl J Med. 2012 Jul 12;367(2):135-45
pubmed: 22784116
Science. 2013 Jan 18;339(6117):286-91
pubmed: 23329041
Eur J Cancer. 2013 Jul;49(11):2476-85
pubmed: 23642327
Nat Genet. 2013 Aug;45(8):927-32
pubmed: 23817572
Transl Oncol. 2013 Dec 01;6(6):784-93
pubmed: 24466382
Tumour Biol. 2014 Jun;35(6):5895-904
pubmed: 24687549
Cancer Res. 2014 Dec 1;74(23):7103-14
pubmed: 25452256
AIDS. 2015 May 15;29(8):867-76
pubmed: 25730507
Oncotarget. 2015 Mar 20;6(8):5846-59
pubmed: 25788271
Oncoimmunology. 2015 Jun 5;4(7):e1058597
pubmed: 26140250
Eur J Cancer. 2015 Nov;51(17):2708-17
pubmed: 26342674
N Engl J Med. 2015 Nov 12;373(20):1979
pubmed: 26559583
Adv Immunol. 2016;130:95-190
pubmed: 26923001
Gut. 2017 Apr;66(4):633-643
pubmed: 26992426
Oncotarget. 2016 Apr 26;7(17):24495-509
pubmed: 27027351
Cancer Cell. 2016 Apr 11;29(4):587-601
pubmed: 27070705
Virology. 2016 Jul;494:198-214
pubmed: 27128349
Open Biol. 2016 Jun;6(6):
pubmed: 27335323
Oncotarget. 2016 Jul 26;7(30):48335-48345
pubmed: 27340784
Oncoimmunology. 2016 Mar 10;5(6):e1150398
pubmed: 27471618
Oncol Rep. 2016 Dec;36(6):3522-3528
pubmed: 27748906
Expert Opin Investig Drugs. 2016 Dec;25(12):1377-1392
pubmed: 27791451
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Sci Rep. 2018 Jan 22;8(1):1323
pubmed: 29358632
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
Int J Mol Sci. 2018 May 16;19(5):null
pubmed: 29772686
Elife. 2018 Sep 04;7:
pubmed: 30179157
Haematologica. 2019 Mar;104(3):564-575
pubmed: 30309853
Clin Cancer Res. 2019 Jul 1;25(13):3873-3886
pubmed: 30890553
Cell Death Dis. 2019 Mar 19;10(4):264
pubmed: 30890699
Br J Cancer. 2019 Apr;120(9):871-882
pubmed: 30936499
Nature. 1996 Jun 20;381(6584):661-6
pubmed: 8649511
Cell. 1996 Jun 28;85(7):1135-48
pubmed: 8674119
Nature. 1996 Aug 22;382(6593):722-5
pubmed: 8751444
Lancet. 1998 Jan 3;351(9095):14-8
pubmed: 9433423